Policy & Medicine – Legal, Regulatory, and Compliance Issues
WEBThomas Sullivan Sep 10, 2024 0. CMS estimates that between 2017 and 2021, Medicare Part A improperly paid $23.9 billion for inpatient hospital stays, with $7.8 billion attributable to short stays that did not qualify for Medicare Part A. On June 13, 2024, the U.S. Department of Health and Human Services’ Office of Inspector General (OIG ...
Home Main – Policy & Medicine
WEBThomas Sullivan Aug 30, 2024 0. As oncology continues to evolve at a rapid pace, staying informed and critical about the latest developments is essential. In the latest episode of Oncology Update with Dr. John Marshall, available on Clinical Care Solutions, we delve into pressing topics and controversies that shape our field.
2021 – Policy & Medicine
WEBFalse Claims Amendments Act of 2021 Continues to Wind Through Congress. Thomas Sullivan Dec 23, 2021 0. Earlier this year, Senator Chuck Grassley and a bipartisan group of senators introduced the False Claims Amendment Act of 2021,…. FDA.
AdvaMed Code Changes Now Effective – Policy & Medicine
WEBAug 17, 2022 · Fraud and Abuse Concerns. The updated Code also provides additional guidance with respect to educational and other health care provider meetings, in light of concerns from the Special Fraud Alert: Speaker Programs issued by HHS OIG in November 2020.. Some of these changes to the AdvaMed Code include advising members to consider specific documentation regarding not only their legitimate need ...
Editorials – Policy & Medicine
WEBOn August 25, 2022, Blood Advances published a new study, authored by Ruemu Birhiray, MD and his daughter, Maya Birhiray, BS, that…
Guidelines – Policy & Medicine
WEBFDA Releases Finalized Guidance on Use of Real-World Data in New Drug and…. Thomas Sullivan Feb 26, 2024 0. Recently, the United States Food and Drug Administration (FDA) finalized two guidance documents that outline how sponsors can use…. Guidelines.
International – Policy & Medicine
WEBThomas Sullivan Nov 15, 2022 0. In September 2022, Johnson & Johnson reached a $204.90 million (A$300 million) settlement in two Australian class action….
Pharmaceutical and Device – Policy & Medicine
WEBLegal, Regulatory, and Compliance Issues. A Detroit-based pension fund filed a proposed class action lawsuit against Amgen, as well as Amgen CEO Robert Bradway and Chief…
COVID-19 – Policy & Medicine
WEBIn light of the Coronavirus (COVID-19) pandemic, the Centers for Medicare and Medicaid Services (CMS) has been implementing…
About Us – Policy & Medicine
WEBAbout Policy & Medicine. Policy & Medicine offers a daily look at legal, regulatory, and compliance issues affecting the pharmaceutical and device industry. Since its inception in 2008, Policy & Medicine has become one of the most widely followed websites in its field. Policy & Medicine provides detailed analysis of many important compliance ...
Skip to content